Baba, Vevencio, JR.. S.
HRN: 14-66-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
CIPROFLOXACIN 500MG (TAB)
05/20/2023
05/27/2023
ORAL
500 Mg
Q12
Acute Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes